Search Trials
For best results, use specific search terms. For example, instead of "brain tumor," try "glioblastoma." You can also contact the Clinical Trials Office at 312-695-1102 for assistance.
OPT2MOVE About the Study Opt2Move is a 6-month smartphone-based study to help adolescent and young adult cancer survivors become more active. What’s involved? Assessments Complete before starting study and at 3 and 6 months: - 45-min online survey
- Wear activity monitor 24/7 for 7 days
- You will be compensated for assessment completion
Physical Activity Program All Participants - Receive Fitbit, Opt2Move app, exercise prescription, 15-min orientation call
- Track physical activity with Fitbit and use Opt2Move app daily
- Additionally, you may receive 0-4 additional Opt2Move features focused on mindfulness and/or social support.
How can I learn more? For questions: Phone: 312-503-3465; Email: O2M@nm.org To complete online screening: https://redcap.link/O2M Eligibility CriteriaWho can participate? - Adults (18-39) diagnosed with cancer (except non-melanoma skin cancer) at age 18-39
- 5 years or less since cancer diagnosis
- 3 months or more since completed primary treatment (i.e., surgery, chemotherapy, and/or radiation); may still be undergoing endocrine or hormonal therapies
- Fluent in spoken and written English
- Own a smartphone that is either an iPhone (version 5 or greater) or an Android (version 5.0 or greater)
- Have internet access
- Have no absolute contraindications to exercise (e.g., acute myocardial infarction, severe orthopedic conditions, or metastatic disease) OR willing to obtain medical clearance from a primary care physician if necessary
- Engage in less than 60 minutes total each week of moderate to vigorous intensity physical activities such as walking, biking, or swimming
- Willing to find a Buddy (someone who knows about your cancer and participation in this study and who is willing to participate by supporting you during the 6-month study)
ClinicalTrials.gov IdentifierNCT05375162IRB number STU00210628 |
